
NASDAQHealthcareMedical - Diagnostics & Research
أحدث البيانات المتاحة
518 US$
+4.86 US$ · +0.95%
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
الإغلاق السابق
518 US$
+4.86 US$ · +0.95%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
نطاق اليوم
السعر الحالي 518 US$
نطاق 52 أسبوعًا
السعر الحالي 518 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
احتفاظ
تقييم
64
أقل من القيمة
المشاعر
68
صعودي
المخاطر
43
مخاطر أعلى من المعتاد
الزخم
42
محايد
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
IDEXX Laboratories, Inc. is a global enterprise focused on creating, producing, and distributing a wide array of products and services. Its primary client base includes companion animal veterinary practices, the livestock and poultry industries, dairy operations, and water quality testing sectors. The company organizes its operations across several key divisions: the Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry, and Dairy (LPD), and additional segments. For companion animals, IDEXX offers a comprehensive suite of point-of-care veterinary diagnostic tools, such as instruments, consumables, and rapid assay kits. It also provides reference laboratory diagnostic and consultation services, alongside practice management and diagnostic imaging solutions for veterinarians. Furthermore, the company supports the biomedical research community with health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services. In the livestock, poultry, and dairy markets, IDEXX supplies diagnostic and health-monitoring solutions. Its water testing portfolio includes products designed to detect various microbiological contaminants, notably the Colilert, Colilert-18, and Colisure tests for total coliforms and E. coli, as well as Enterolert, Pseudalert, Filta-Max, Filta-Max xpress, Legiolert, and Quanti-Tray products. Beyond these, IDEXX extends its reach to human point-of-care medical diagnostics, offering electrolyte and blood gas analyzers, and SARS-CoV-2 RT-PCR tests. Other key offerings encompass in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers, as well as SNAP rapid assay test kits. Veterinary software and services for both independent clinics and large corporate veterinary groups are also part of its offerings. The company distributes its extensive product and service catalog through its own dedicated marketing, customer service, sales, and technical service teams, supplemented by independent distributors and other resellers. IDEXX Laboratories, Inc. was established in 1983 and maintains its headquarters in Westbrook, Maine.
نطاق اليوم
السعر الحالي 518 US$
نطاق 52 أسبوعًا
السعر الحالي 518 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 | السنة المالية 2021 |
|---|---|---|---|---|---|
| الإيرادات | 4.3 مليار USD | 3.9 مليار USD | 3.66 مليار USD | 3.37 مليار USD | 3.22 مليار USD |
| تكلفة البضاعة المباعة | 1.64 مليار USD | 1.52 مليار USD | 1.47 مليار USD | 1.36 مليار USD | 1.33 مليار USD |
| الربح الإجمالي | 2.66 مليار USD | 2.38 مليار USD | 2.19 مليار USD | 2 مليار USD | 1.89 مليار USD |
| البحث والتطوير | 251.21 مليون USD | 219.79 مليون USD | 190.95 مليون USD | 254.82 مليون USD | 161.01 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 1.05 مليار USD | 1.03 مليار USD | 901.89 مليون USD | 850.75 مليون USD | 796.4 مليون USD |
| نفقات التشغيل | 1.3 مليار USD | 1.25 مليار USD | 1.09 مليار USD | 1.11 مليار USD | 957.4 مليون USD |
| دخل الفوائد | 2.42 مليون USD | 12.7 مليون USD | 5.63 مليون USD | 1.07 مليون USD | 434 ألف USD |
| مصاريف الفوائد | 38.27 مليون USD | 31.21 مليون USD | 41.58 مليون USD | 39.86 مليون USD | 29.81 مليون USD |
| الاستهلاك والإطفاء | 145.18 مليون USD | 129.94 مليون USD | 114.91 مليون USD | 111.9 مليون USD | 104.6 مليون USD |
| الدخل التشغيلي | 1.36 مليار USD | 1.13 مليار USD | 1.1 مليار USD | 898.77 مليون USD | 932.03 مليون USD |
| صافي الدخل | 1.06 مليار USD | 887.87 مليون USD | 845.04 مليون USD | 679.09 مليون USD | 744.85 مليون USD |
تم تحديث حقائق الشركة 11 أكتوبر 2026.
النتائج المعلنة مع توقعات الإجماع المتاحة.
النتائج المعلنة مع توقعات الإجماع المتاحة.
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
| الإجراء | تاريخ النفاذ | تفاصيل | تاريخ التسجيل | تاريخ الدفع |
|---|---|---|---|---|
تقسيم الأسهم | 16 يونيو 2015 | 2:1 | — | — |
تقسيم الأسهم | 27 نوفمبر 2007 | 2:1 | — | — |
تقسيم الأسهم | 6 يونيو 1995 | 2:1 | — | — |
تقسيم الأسهم | 4 أكتوبر 1993 | 2:1 | — | — |
ساري 16 يونيو 2015
2:1
ساري 27 نوفمبر 2007
2:1
ساري 6 يونيو 1995
2:1
ساري 4 أكتوبر 1993
2:1
صناديق متداولة تفصح عن تعرضها لهذا السهم.
State Street SPDR S&P 500 ETF1557.T78.47 مليار0.06%129.35 ترليون JPY0.09%122,850 JP¥+0.12%
Vanguard Morningstar Total Stock Market ETFVTI1.4 مليار0.06%2.3 ترليون USD0.03%381.94 US$+0.63%
Vanguard S&P 500 ETFVOO1.17 مليار0.07%1.8 ترليون USD0.03%715.59 US$+0.61%
Vanguard Morningstar Mid-Cap ETFVO949.87 مليون0.42%226.4 مليار USD0.03%81.14 US$+0.92%
Invesco QQQ Trust, Series 1QQQ850.94 مليون0.17%506.07 مليار USD0.18%751.27 US$+0.49%
iShares Core S&P 500 ETFIVV537.54 مليون0.06%896.44 مليار USD0.03%781.97 US$+0.60%
Vanguard Morningstar Growth ETFVUG519.98 مليون0.14%384.6 مليار USD0.03%91.97 US$+0.72%
State Street SPDR S&P 500 ETFSPY495.63 مليون0.06%817.2 مليار USD0.09%778.57 US$+0.60%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
Vanguard Morningstar Mid-Cap ETFVO
Invesco QQQ Trust, Series 1QQQ
iShares Core S&P 500 ETFIVV
Vanguard Morningstar Growth ETFVUG
State Street SPDR S&P 500 ETFSPYالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.